CVEvulnerability

CVE-2015-3956

9.8 CRITICAL Published 2019-03-25 Modified 2026-06-17 Official page ↗
Status
Modified
Published
2019-03-25
Last modified
2026-06-17
Assigner
[email protected]
CVSS 3.0 ([email protected])
9.8 CRITICAL — CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CVSS 2.0 ([email protected])
10.0 HIGH — AV:N/AC:L/Au:N/C:C/I:C/A:C
Weaknesses
CWE-345

Description

Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior accept drug libraries, firmware updates, pump commands, and unauthorized configuration changes from unauthenticated devices on the host network. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.

Affected configurations

• pifzer plum a\+ infusion system firmware (<= 13.4) • pifzer plum a\+3 infusion system firmware (<= 13.6) • pifzer symbiq infusion system firmware (<= 3.13)

Related

Weakness · CWE (1)

  • CWE-345 Insufficient Verification of Data Authenticity weakness

References